Improved stent characteristics for prophylaxis of post-ERCP pancreatitis

Clinical Gastroenterology and Hepatology

Volumn 2, Issue 4, 2004, Pages 322-329

  Rashdan, Abdullah ^a   Fogel, Evan L ^a   McHenry Jr , Lee ^a   Sherman, Stuart ^a   Temkit, M'Hamed ^a   Lehman, Glen A ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Endoscopic retrograde cholangiopancreatography; ERCP; SOD; Sphincter of Oddi dysfunction

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS DUCT; PANCREATITIS; PERFORATION; PROPHYLAXIS; STENT; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; COHORT STUDIES; EQUIPMENT DESIGN; EQUIPMENT SAFETY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MATERIALS TESTING; MIDDLE AGED; PANCREATITIS; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SPHINCTEROTOMY, ENDOSCOPIC; STENTS;

EID: 1842427482     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(04)00062-X     Document Type: Article

References (40)

1. Freeman M.L. Adverse outcomes of ERCP. Gastrointest Endosc. 56:(suppl 6):2002;S273-S282.
2. Smith M.T., Sherman S., Nisi R., Ikenberry S.O., Hawes R.H., Lehman G.A. Alterations in pancreatic ductal morphology following polyethylene pancreatic stent therapy. Gastrointest Endosc. 44:1996;268-275.
3. Kozarek R.A. Pancreatic stents can induce ductal changes consistent with chronic pancreatitis. Gastrointest Endosc. 36:1990;93-95.
4. Derfus G.A., Geenen J.E., Hogan W.J. Effects of endoscopic pancreatic duct stent placement on pancreatic ductal morphology (abstr). Gastrointest Endosc. 36:1990;206A.
5. Burdick J.S., Geenen J.E., Venu R.P., Schmalz M.J., Johnson G.K., Shakoor T. Ductal morphological changes due to pancreatic stent therapy - a randomized controlled study. Am J Gastroenterol. 87:1992;155A. (abstr).
6. Gulliver D.J., Edmunds S., Baker M.D., Paine S., Baillie J., Cotton P.B., Rice R.P. Stent placement for benign pancreatic diseases correlation between ERCP findings and clinical response. AJR Am J Roentgenol. 159:1992;751-755.
7. Rossos P.G., Kortan P., Haber G.B. Complications associated with pancreatic duct stenting. Gastrointest Endosc. 38:1992;252A. (abstr).
8. Lehman G.A., Sherman S., Nisi R., Hawes R.H. Pancreas divisum results of minor papilla sphincterotomy. Gastrointest Endosc. 39:1993;1-8.
9. Eisen G., Coleman S., Troughton A., Cotton P.B. Morphological changes in the pancreatic duct after stent placement for benign pancreatic disease. Gastrointest Endosc. 40:1994;107A. (abstr).
10. Sherman S., Hawes R.H., Savides T.J., Gress F.G., Ikenberry S.O., Smith M.T., Zaidi S., Lehman G.A. Stent-induced pancreatic ductal and parenchymal changes correlation of endoscopic ultrasound with ERCP. Gastrointest Endosc. 44:1996;276-282.
11. Cotton P.B., Lehman G., Vennes J., Geenen J.E., Russell R.C.G., Meyers W.C., Liguory C., Nickl N. Endoscopic sphincterotomy complications and their management an attempt at consensus. Gastrointest Endosc. 37:1991;383-393.
12. Axon A.T.R., Classen M., Cotton P.B., Cremer M., Freeny P.C., Lees W.R. Pancreatography in chronic pancreatitis international definitions. Gut. 25:1984;1107-1112.
13. Fogel E., Sherman S., Gottlieb K., Olssen M., Lehman G.A. Spontaneous dislodgment of unflanged pancreatic duct stents a final analysis. Gastrointest Endosc. 47:1998;AB136. (abstr).
14. Fogel E., Sherman S., Rerknimitr R., Devereaux B., Kochell A., Flueckiger J., Lehman G.A. Spontaneous dislodgment rates of long length, small diameter, "unflanged" pancreatic stents placed partially up the duct. Gastrointest Endosc. 51:2000;AB180. (abstr).
15. Tarnasky P., Palech Y., Cunningham J., Mauldin P., Cotton P., Hawes R.H. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology. 115:1998;1518-1524.
16. Jacob L., Geenen J.E., Catalano M.F., Geenen D.J. Prevention of pancreatitis in patients with idiopathic recurrent pancreatitis a prospective non-blinded randomized study using endoscopic stents. Endoscopy. 33:2001;559-562.
17. Ohshio G., Saluja A., Steer M.L. Effects of short-term pancreatic duct obstruction in rats. Gastroenterology. 100:1991;196-202.
18. Lerch M.M., Saluja A.K., Runzi M., Dawra R., Saluja M., Steer M.L. Pancreatic duct obstruction triggers acute necrotizing pancreatitis in the opossum. Gastroenterology. 104:1993;853-861.
19. Freeman M.L., Nelson D.B., Sherman S., Haber G.B., Herman M.E., Dorsher P.J., Moore J., Fennerty B., Rayan M., Shaw M., Lande J., Pheley A. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 335:1996;909-918.
20. Gottlieb K., Sherman S. ERCP and endoscopic biliary sphincterotomy- induced pancreatitis. Gastrointest Endosc Clin N Am. 8:1998;87-114.
21. Freeman M.L., DiSario J.A., Nelson D.B., Fennerty M.B., Lee J.G., Bjorkman D.J., Overby C.S., Aas J., Ryan M., Bochna G., Shaw M., Sandy H., Erickson R.V., Moore J.P., Roel J.P. Risk factors for post-ERCP pancreatitis a prospective, multicenter study. Gastrointest Endosc. 54:2001;425-434.
22. Loperfido S., Angelini G., Benedetti G., Chilovi F., Costan F., De Berardinis F., De Bernardin M., Ederle A., Fina P., Fratton A. Major early complications from diagnostic and therapeutic ERCP a prospective multicenter study. Gastrointest Endosc. 48:1998;1-10.
23. Sherman S., Lehman G.A. ERCP- and endoscopic sphincterotomy-induced pancreatitis. Pancreas. 6:1991;350-367.
24. Sherman S., Ruffolo T.A., Hawes R.H., Lehman G.A. Complications of endoscopic sphincterotomy a prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and non dilated ducts. Gastroenterology. 101:1991;1068-1075.
25. Sherman S., Hawes R.H., Rathgaber S.W., Uzer M.F., Smith M.T., Khusro Q.E., Silverman W.B., Earle D.T., Lehman G.A. Post ERCP pancreatitis randomized, prospective study comparing a low- and high-osmolality contrast agent. Gastrointest Endosc. 40:1994;422-427.
26. Johnson G.K., Geenen J.E., Bedford R.A., Johanson J., Cass O., Sherman S., Hogan W.J., Ryan M., Silverman W., Edmundowicz S., other members of the Midwest Pancreatobiliary Study Group. A comparison of nonionic versus ionic contrast media results of a prospective, multicenter study. Gastrointest Endosc. 42:1995;312-316.
27. LaFerla G., Gordon S., Archibald M., Murray W.R. Hyperamylasemia and acute pancreatitis following endoscopic retrograde cholangiopancreatography. Pancreas. 1:1986;160-163.
28. Tarnasky P.R., Cunningham J.T., Hawes R.H., Hoffman B.J., Uflacker R., Vujic I., Cotton P.B. Transpapillary stenting of proximal biliary strictures does biliary sphincterotomy reduce the risk of post procedure pancreatitis? Gastrointest Endosc. 45:1997;46-51.
29. Tarnasky P.R., Cunningham J.T., Cotton P.B., Hoffman B.J., Palesch Y., Freeman J., Curry N., Hawes R.H. Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis. Endoscopy. 29:1997;252-257.
30. Smithline A., Silverman W., Rogers D., Nisi R., Wiersema M., Jamidar P., Hawes R.H., Lehman G.A. Effects of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest Endosc. 39:1993;652-657.
31. Sherman S., Earle D., Bucksot L., Baute P., Gottlieb K., Lehman G. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy (ES)-induced pancreatitis? A final analysis of a randomized prospective study. Gastrointest Endosc. 43:1996;A489. (abstr).
32. Vandervoort J., Tham T., Wong R., Van Dam J., Lichtenstein D.R., Ruymann F., Hughes M., Carr-Locke D.L. Risk of manipulating the pancreatic duct during ERCP. Am J Gastroenterol. 91:1996;1945. (abstr).
33. Fazel A., Quadri A., Catalano M.F., Meyerson S.M., Geenen J.E. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc. 57:2003;291-294.
34. Patel R., Tarnasky P.R., Hennessy W.S., Hawes R.H., Payne K.M., Nelles S.E., Cunningham J.T., Cotton P.B. Does stenting after pancreatic sphincterotomy reduce post-ERCP pancreatitis in patients with prior biliary sphincterotomy? Preliminary results of a prospective randomized trial. Gastrointest Endosc. 49:1999;AB80. (abstr).
35. Aizawa T., Ueno N. Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones. Gastrointest Endosc. 54:2001;209-213.
36. Fogel E., Eversman D., Jamidar P., Sherman S., Lehman G.A. Sphincter of Oddi dysfunction pancreatobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy. 34:2002;280-285.
37. Smits M.E., Badiga S.M., Rauws E.A., Tytgat G.N., Huibregtse K. Long-term results of pancreatic stents in chronic pancreatitis. Gastrointest Endosc. 42:1995;461-467.
38. Mergener K., Kozarek R.A. Therapeutic pancreatic endoscopy. Endoscopy. 35:2003;48-54.
39. Siegel J., Veerappan A. Endoscopic management of pancreatic disorders potential risks of pancreatic prosthesis. Endoscopy. 23:1991;177-180.
40. Sherman S., Alvarez C., Robert M., Ashley S.W., Reber H.A., Lehman G.A. Polyethylene pancreatic duct stent-induced changes in the normal dog pancreas. Gastrointest Endosc. 39:1993;658-664.